Canada Inhibitors Research
14 comprehensive market analysis studies and research reports on the Canada Inhibitors sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 146 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
CAGR: 3.53%
Study Period: 2020 - 2031
Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
CAGR: 3.03%
Study Period: 2020 - 2031
Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market
CAGR: 9%
Study Period: 2019 - 2030
Asia-Pacific Alpha-Glucosidase Inhibitors Market
CAGR: 2.30%
Study Period: 2019 - 2030
Middle East and Africa Alpha-Glucosidase Inhibitors Market
CAGR: 3.60%
Study Period: 2019 - 2030
Healthcare
Categories
14 Healthcare Reports
Categories
Showing 14 of 14 results in Inhibitors
Montelukast API Market
CAGR: 11.75%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:Morepen Laboratories Limited, Dr. Reddy’s Laboratories Limited, Teva Pharmaceutical Industries, Aurobindo Pharma, Sun Pharmaceuticals Industries
Starting at:$4,750
Tyrosine Kinase Inhibitors Market
CAGR: 7.91%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:Boehringer Ingelheim, Roche, AstraZeneca, Novartis, Bayer
Starting at:$4,750
PD-1 And PD-L1 Inhibitors Market
CAGR: 13.88%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:Bristol-Myers Squibb, Merck, Roche, Pfizer, GlaxoSmithKline
Starting at:$4,750
North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
CAGR: 2.81%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck, Novartis
Starting at:$4,750
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
CAGR: 2.61%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck, Pfizer
Starting at:$4,750
Enzyme Inhibitors Market
CAGR: 3.95%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Canada
Major Players:Abbott Laboratories, AstraZeneca, Bayer, Boehringer Ingelheim, Amgen
Starting at:$4,750
Global Interleukin Inhibitors Market
CAGR: 14.64%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:Abbvie, Johnson & Johnson, Novartis, Eli Lilly and Company, GlaxoSmithKline
Starting at:$4,750
Esomeprazole Market
CAGR: 6.08%
Study Period: 2022 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:Teva Pharmaceutical Industries, Amneal Pharmaceuticals, Viatris, Daiichi Sankyo, Sun Pharmaceuticals Industries
Starting at:$4,750
Imatinib Drug Market
CAGR: 3%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Canada
Major Players:Sun Pharmaceuticals Industries, Novartis, Teva Pharmaceutical Industries, Mylan, Dr. Reddy’s Laboratories
Starting at:$4,750
Immune Checkpoint Inhibitors Market
CAGR: 16.18%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:Bristol-Myers Squibb, Regeneron Pharmaceuticals, Roche, AstraZeneca, Merck
Starting at:$4,750
Tumor Necrosis Factor Inhibitors Market
CAGR: 3.59%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:Pfizer, Johnson & Johnson, Amgen, Abbvie, UCB
Starting at:$4,750
Plasma Protease C1-inhibitor Market
CAGR: 9.12%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:CSL Behring, Takeda Pharmaceuticals, Pharming Technologies B.V., KalVista Pharmaceuticals, BioCryst Pharmaceuticals
Starting at:$4,750
Alpha-glucosidase Inhibitors Market
CAGR: 2.17%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Canada
Major Players:Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer
Starting at:$4,750
Proton Pump Inhibitors Market
CAGR: 5.14%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Canada
Major Players:Bayer, Pfizer, Takeda Pharmaceuticals, Zydus Group, AstraZeneca
Starting at:$4,750
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
